High Intensity Focused Ultrasound

Global High Intensity Focused Ultrasound Market to Reach US$1.8 Billion by 2030

The global market for High Intensity Focused Ultrasound estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Uterine Fibroids Detection, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$521.6 Million by the end of the analysis period. Growth in the Prostate Cancer Detection segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$346.3 Million While China is Forecast to Grow at 10.3% CAGR

The High Intensity Focused Ultrasound market in the U.S. is estimated at US$346.3 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$383.8 Million by the year 2030 trailing a CAGR of 10.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global High-Intensity Focused Ultrasound (HIFU) Market – Key Trends & Drivers Summarized

How is HIFU Revolutionizing Non-Invasive Therapeutics?

High-Intensity Focused Ultrasound (HIFU) is redefining modern medical treatments by offering a non-invasive alternative for various therapeutic and diagnostic applications. This cutting-edge technology employs focused ultrasound waves to generate precise thermal ablation in targeted tissues, effectively treating conditions such as prostate cancer, uterine fibroids, pancreatic tumors, and even neurological disorders. Unlike traditional surgery, HIFU eliminates the need for incisions, thereby reducing patient recovery time, risk of infection, and overall healthcare costs. Its growing adoption in oncology is particularly noteworthy, as it provides localized tumor destruction while preserving surrounding healthy tissue. Furthermore, ongoing research into HIFU’s neurotherapeutic potential is expanding its scope to conditions such as essential tremors and Parkinson’s disease, offering hope for non-invasive brain modulation. The integration of HIFU with advanced imaging modalities, such as MRI and ultrasound guidance, is enhancing precision and treatment outcomes, making it a preferred choice in specialized clinical settings. Additionally, the technology is gaining traction in cosmetic dermatology for skin tightening and body contouring, further broadening its market appeal. As the demand for minimally invasive medical procedures continues to surge, HIFU is positioned as a transformative force in modern medicine, paving the way for safer and more efficient therapeutic interventions.

What Are the Emerging Applications of HIFU Beyond Oncology?

While HIFU has gained widespread recognition for its efficacy in cancer treatment, emerging applications are unlocking new avenues in regenerative medicine, pain management, and targeted drug delivery. In cardiovascular medicine, researchers are investigating HIFU’s potential for treating arrhythmias and arterial plaque removal, offering a novel non-invasive solution to complex vascular conditions. Additionally, HIFU is being explored for orthopedic treatments, including non-surgical intervention for osteoarthritis and accelerated bone healing through localized tissue stimulation. In regenerative medicine, the use of HIFU to enhance stem cell proliferation and differentiation is creating promising opportunities for tissue repair and organ regeneration. Another breakthrough application lies in neuromodulation, where focused ultrasound waves are being used to modulate neural activity, showing promise in treating conditions such as depression, epilepsy, and chronic pain syndromes. Moreover, advancements in sonodynamic therapy (SDT), which combines HIFU with sonosensitizers to enhance targeted cancer cell destruction, are gaining traction in preclinical studies. The technology is also making headway in veterinary medicine, offering non-invasive tumor treatment options for animals. These diverse applications underscore HIFU’s vast potential beyond oncology, positioning it as a versatile therapeutic tool capable of addressing a wide range of medical challenges across multiple specialties.

What Are the Technological Innovations Driving HIFU Advancements?

Recent technological innovations are significantly enhancing the efficacy, safety, and accessibility of HIFU treatments. One of the most notable advancements is the integration of real-time imaging techniques, such as MRI-guided and ultrasound-guided HIFU, which provide precise targeting and continuous monitoring of thermal effects. This has led to improved accuracy in treatment planning and execution, reducing the risk of complications. Additionally, advancements in transducer technology, including phased array transducers, allow for better energy modulation and adaptive focusing, ensuring optimal therapeutic outcomes. Artificial intelligence (AI) and machine learning algorithms are also being leveraged to automate treatment planning, enabling personalized therapy adjustments based on patient-specific anatomical and physiological parameters. Furthermore, research into cavitation control and temperature mapping is enhancing the predictability and safety of HIFU procedures, minimizing unintended tissue damage. Another breakthrough is the development of portable and low-cost HIFU devices, aimed at making the technology more accessible in outpatient settings and emerging markets. The synergy between HIFU and targeted drug delivery systems is also opening new frontiers, as researchers explore how ultrasound waves can enhance drug penetration into tumors and other difficult-to-reach tissues. With continuous R&D efforts, HIFU technology is evolving rapidly, offering more precise, effective, and patient-friendly treatment options across a growing range of medical disciplines.

What Is Driving the Rapid Growth of the HIFU Market?

The growth in the High-Intensity Focused Ultrasound (HIFU) market is driven by several factors, including increasing demand for non-invasive medical procedures, rising prevalence of cancer and chronic diseases, and rapid technological advancements. The growing preference for outpatient and ambulatory care is fueling the adoption of HIFU, as it offers an effective alternative to surgery without extended hospital stays. Additionally, the expanding geriatric population, which is more susceptible to conditions like prostate cancer and neurological disorders, is further boosting market demand. Regulatory approvals and favorable reimbursement policies in key markets, including the U.S., Europe, and China, are accelerating HIFU adoption, making it more accessible for patients. The rising investment in medical research and the proliferation of clinical trials evaluating HIFU’s efficacy across new indications are strengthening market prospects. In the cosmetic and aesthetic sector, increasing consumer awareness and demand for non-invasive skin rejuvenation treatments are driving growth in HIFU-based dermatological applications. Moreover, the growing adoption of AI-powered treatment planning tools and real-time monitoring systems is enhancing procedural accuracy, making HIFU more attractive to healthcare providers. The expansion of private healthcare infrastructure in emerging economies, coupled with increasing affordability of HIFU systems, is creating new opportunities for market penetration. Collaborations between medical device manufacturers and research institutions are further propelling innovation, leading to the continuous development of next-generation HIFU solutions. These combined factors are setting the stage for robust market expansion, solidifying HIFU’s position as a cornerstone of modern non-invasive therapeutic strategies.

SCOPE OF STUDY:

The report analyzes the High Intensity Focused Ultrasound market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Detection (Uterine Fibroids Detection, Prostate Cancer Detection, Essential Tremors Detection, Dermatology Detection, Breast Cancer Detection, Glaucoma Detection, Backpain Detection, Facetogenic Detection, Other Detection); End-Use (Hospitals End-Use, Imaging Centers End-Use, Other End-Users)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Alpinion Medical Systems Co., Ltd.
• Chongqing Haifu Medical Technology Co., Ltd.
• EDAP TMS
• FUJIFILM VisualSonics Inc.
• FUS Instruments
• Insightec Ltd.
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• Medtronic Plc
• Mianyang Sonic Electronic Ltd.
• Profound Medical Corp.
• Shanghai A&S Co., Ltd.
• Sofwave Medical Ltd.
• Sonablate Corp.
• SonaCare Medical, LLC
• Stryker Corporation
• SuperSonic Imagine
• Theraclion
• Ultrasound Technologies Ltd.
• Verasonics, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.